The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Bulgakov S.A.

Pirogov Russian National Research Medical University

Opioid peptides in the regulation of eating behavior and appetite. (A Narrative Review)

Authors:

Bulgakov S.A.

More about the authors

Read: 3484 times


To cite this article:

Bulgakov SA. Opioid peptides in the regulation of eating behavior and appetite. (A Narrative Review). Russian Journal of Evidence-Based Gastroenterology. 2024;13(1):79‑85. (In Russ.)
https://doi.org/10.17116/dokgastro20241301179

Recommended articles:
Modern view on the etiology of gallstone disease in children. Russian Journal of Evidence-Based Gastroenterology. 2024;(4):59-68
Application of modern methods for acti­vation of brain functions in obese patients (literature review). Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(6):54-61
Chro­nic inflammation in case of obesity-associated diseases. Russian Journal of Preventive Medi­cine. 2025;(1):115-121
Identification of prognostic significant markers of early diagnosis of obesity and meta­bolic diso­rders. Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(6-2):71-79

References:

  1. Dedov II, Mel’nichenko GA. Ozhirenie. M.: MIA; 2004; 8, 44-73, 234-266. (In Russ.).
  2. Demidova TYu, Grickevich EYu. Ozhirenie i komorbidnye sostoyaniya: sovremennye metody upravleniya i ozhidaemye perspektivy. M.: RNIMU; 2018. (In Russ.).
  3. Andreev DN, Kucheryavyj YuA. Ozhirenie i gastroenterologicheskaya komorbidnost’. M.: Prima Print; 2021. (In Russ.).
  4. Ljaljukova EA, Beslangurova ZA, Chamokova AYa, Halashte AA, Migunova YuYu. Humoral regulation of eating behavior: established and new concepts. Lechaschiy vrach. 2023;4(26):23-28. (In Russ.). https://doi.org/10.51793/OS.2023.26.4.003
  5. Zvenigorodskaya LA, Mishchenkova TV, Tkachenko EV. Hormones and types of eating behavior, endocannabinoid system, food addiction in the development of metabolic syndrome. Gastroenterologiya. 2009;1:73-83. (In Russ.).
  6. Goldstein A, Schulz R. Morphine tolerant longitudinal muscle strips from guinea pig ileum. British Journal of Pharmacology. 1973; 48(4):655-666. 
  7. Bulgakov SA. Dalargin v gastroenterologii. M.: OOO «Megard Grupp»; 2008. (In Russ.).
  8. Smagin VG, Vinogradov VA, Bulgakov SA. Ligandy opiatnyh receptorov. M.: Nauka; 1983. (In Russ.).
  9. Morley JE, Levine AS. Stress-induced eating is mediated through endogenous opiates. Science. 1980;209(4462):1259-1261. https://doi.org/10.1126/science.6250222
  10. Grandison I, Guidotti A. Simulation of food intake by muscimol and B-endorphin. Neuropharmacology. 1977;16(7-8):533-536.  https://doi.org/10.1016/0028-3908(77)90019-3
  11. McGivern R, Stein I, Belluzzi J. Potent analgesic activity of the enkephalin-like tetrapeptide. Life Sciences. 1978;23(13):1371-1378. https://doi.org/10.1016/0024-3205(78)90396-x
  12. Bolotova NV, Kurdiyan MS, Filina NYu. Neuroendocrine mechanisms of regulation of eating behavior (review). Saratovskij nauchno-medicinskij zhurnal. 2020;16(3):707-713. (In Russ.).
  13. Ambinder R, Schuster M. Endorphins: New gut peptides with a familiar face. Gastroenterology. 1979;77(5):1132-1140.
  14. Korot’ko GF. Fiziologiya sistemy pishchevareniya. Krasnodar: OOO BK «Gruppa B»; 2009. (In Russ.).
  15. Bulgakov SA. Endogenous opioids in the regulation of appetite and eating behavior. Rossijskij zhurnal gastroe`nterologii, gepatologii, koloproktologii. 2023;33(5):43. (In Russ.).
  16. Vijayan E, McCann S. In vivo and in vitro effects of substance P and neurotensin on gonadotropin and prolactin release. Endocrinology. 1979;105(1):64-68.  https://doi.org/10.1210/endo-105-1-64
  17. Erspejmer V, Melhiori P, Erspejmer F, Negri L. Polipeptidy iz kozhi amfibij, dejstvuyushchie na kishechnik i ih analogi u mlekopitayushchih. Zheludochno-kishechnye gormony. M.: Medicina; 1981;53-66. (In Russ.).
  18. Gibbs J, Young R, Smith G. Cholecysyokinin-descreased food intake in rhesus monkeys. American Journal of Physiology. 1976; 230(1):15-18.  https://doi.org/10.1152/ajplegacy.1976.230.1.15
  19. Engeli S, Böhnke J, Feldpausch M, Gorzelniak K, Janke J, Bátkai S, Pacher P, Harvey-White J, Luft FC, Sharma AM, Jordan J. Activation of the peripheral endocannabinoid system in human obesity. Diabetes. 2005;54:2838-2843. https://doi.org/10.2337/diabetes.54.10.2838
  20. Mackie K. Cannabinoid receptors as therapeutic targets. Annual Review of Pharmacology and Toxicology. 2006;46:101-32.  https://doi.org/10.1146/annurev.pharmtox.46.120604.141254
  21. Bulgakov SA. Hexapeptide dalargin in clinical gastroenterology: 30 years’ of clinical application of the drug. Rossijskij zhurnal gastroe`nterologii, gepatologii, koloproktologii. 2016;26(3):103-112. (In Russ.). https://doi.org/10.22416/1382-4376-2016-26-3-103-112
  22. Minushkin ON, Maslovskiy LV. Etiological aspects of the treatment of chronic pancreatitis. Consilium medicum. 2005;6(7):444-447. (In Russ.).
  23. Doncov AV. Dalargin in the correction of anxiety and depressive disorders in patients with metabolic syndrome. Farmaciya. 2013;6:44-45. (In Russ.).
  24. Sirotin BZ, Ushakova OV, ZHmereneckij KV. Dalargin in the complex treatment of patients with diabetic foot syndrome.TOP-medicina. 2000;5:29-31. (In Russ.)
  25. Perevedentseva SE, Savinova NV, Trofimova SR, Danilova OV, Naumova NG. The effect of the synthetic analogue of ley-enkefalin on the collagen content in the liver of rats with alloxan diabetes. Zdorov’e, demografiya, ekologiya finno-ugorskih narodov. 2022;2:54-58. (In Russ.).
  26. Sergalieva MU, Tsibizova AA, Krintsova TA, Samotrueva MA. Opioid peptides: physiological role, molecular mechanisms and pharmacological activity. Rossijskij zhurnal boli. 2023;21(3):43-49. (In Russ.). https://doi.org/10.17116/pain20232103143
  27. Navolockaya EV. Octarfin is a non-opioid peptide of opioid origin. Bioorganicheskaya himiya. 2015;41(5):524. (In Russ.).
  28. Kosorukov VS, Abuzarova GR, Zakharochkina ER, Gamzeleva OYu, Yatsenko KA. Tafalgin is a Russian innovative tetrapeptide pharmaceutical for subcutaneous injection: review of the results of phase I and II clinical trials. Opukholi golovy` i shei. 2022;12(2): 89-107. (In Russ.). https://doi.org/10.17650/2222-1468-2022-12-2-89-107

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.